SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (23688)5/18/2007 3:59:15 PM
From: f_mcknuckles  Respond to of 52153
 
Cancer in mixed breeds-
>>I suppose it could be some sort of recessive protective gene that occurs in some pure-bred breeds. Generally we assume mutations specific to a breed are all deleterious, but I don't see any reason why there couldn't be an occasional exception<<

That's exactly why I was interested. I could understand recessive protection in some breeds, but all? Huskies are the only breed that have a higher incidence of cancer than mixed-breeds. So this probably isn't the explanation.

Thanks for the link to dog genome and disease - perfect for a very slow Friday!



To: Biomaven who wrote (23688)5/18/2007 4:14:05 PM
From: tuck  Read Replies (2) | Respond to of 52153
 
Peter or anyone,

Roche has a PDUFA date of May 20th for Mircera, as I'm sure you know.

Message 23550682

Since that's this Sunday, when is the FDA most likely to say something? This afternoon/evening? Or Monday? I've been expecting some kind of extension, myself, but they have to say something soon, don't they? And where would this news item first appear in the public domain? Somewhere on the FDA website?

TIA & Cheers, Tuck